Ignite Creation Date:
2024-05-06 @ 8:33 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02767752
Status:
TERMINATED
Last Update Posted:
2018-07-10
First Post:
2016-05-06
Brief Title:
Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer
Sponsor:
Herlev Hospital
Organization:
Herlev Hospital
Organization Data
Organization:
Herlev Hospital
Class:
OTHER
Study ID:
GI 1604
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herlev Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Inna Chen MD
Responsible Party Title:
Staff specialist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Herlev Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GENIS | UNKNOWN |